Correlation Between Dermata Therapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Dermata Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Dermata Therapeutics and Reviva Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Dermata and Reviva is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Reviva Pharmaceuticals
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 2.46 times less risky than Reviva Pharmaceuticals. The stock trades about -0.21 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 116.00 in Reviva Pharmaceuticals Holdings on August 31, 2024 and sell it today you would lose (2.00) from holding Reviva Pharmaceuticals Holdings or give up 1.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Dermata Therapeutics vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Dermata Therapeutics |
| Reviva Pharmaceuticals |
Dermata Therapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Dermata Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |